
Drexel Pharma Private Limited
About Drexel Pharma Private Limited
Data last updated:
Drexel Pharma Private Limited is a private limited company based in Silvassa, Dadra And Nagar Haveli, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 18 November 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51900DN1987PTC005546.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vijay Thakorbhai Desai and Ajay Thakorbhai Desai.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at G – 1 Krunal Apartment Opp. Vinoba Bhave Civil Hospital Silvassa Dadra And Nagar Have, Li, Dadra and Nagar Haveli, India – 396230.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Drexel Pharma has one previous CIN (Corporate Identification Number): U51900MH1987PTC045339. The current CIN is U51900DN1987PTC005546, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51900DN1987PTC005546 | Current |
| U51900MH1987PTC045339 | Previous |
Contact details
Drexel Pharma Private Limited's registered office is in Silvassa, Dadra And Nagar Haveli. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG – 1 Krunal Apartment Opp. Vinoba Bhave Civil Hospital Silvassa Dadra And Nagar Have, Li, Dadra and Nagar Haveli, India – 396230
- IndustryAgriculture, Crop Protection
To see the full contact details of Drexel Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Drexel Pharma Private Limited
FY 2024 filings availableDrexel Pharma Private Limited reported revenue of ₹2,983 (up 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Drexel Pharma Private Limited, buy the company report.
Board of directors of Drexel Pharma Private Limited
Drexel Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Thakorbhai Desai Also directs: DNH Projects Limited, Morai Infrastructure Private Limited | Director | 15 Jan 2011 | 15 Years 10 Months | Current |
| Ajay Thakorbhai Desai | Director | 15 Jan 2011 | 15 Years 10 Months | Current |
Peer comparison
Drexel Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M D Marketing Private Limited | ₹3,500 (FY 2025) | -100.0% | Delhi, India | |||
| Srish Chem Private Limited | ₹3,478 (FY 2019) | -98.0% | Bhiwandi, Maharashtra, India | |||
| Skynet Overseas Private Limited | ₹3,417 (FY 2025) | -100.0% | New Delhi, Delhi, India | |||
| India Health Services Private Limited | ₹3,216 (FY 2025) | -99.0% | Chandigarh, India | |||
| Superking Silicate Private Limited | ₹3,082 (FY 2023) | Himatnagar, Gujarat, India | ||||
| Drexel Pharma Private Limitedthis company | ₹2,983 (FY 2024) | 18.0% | Silvassa, Dadra And Nagar Haveli, India | |||
| Jy Finechem Private Limited | ₹2,920 (FY 2024) | Hyderabad, Telangana, India | ||||
| High-Rise Chemical Industries Private Limited | ₹2,780 (FY 2025) | -99.0% | Navi Mumbai, Maharashtra, India | |||
| Levantex Pharmaceuticals Private Limited | ₹2,662 (FY 2025) | Secunderabad, Telangana, India | ||||
| Samast Chemicals Private Limited | ₹2,650 (FY 2025) | 80.0% | Hyderabad, Telangana, India | |||
| Oxygen City Private Limited | ₹2,617 (FY 2025) | -98.0% | Nashik, Maharashtra, India |
To see the full peer comparison of Drexel Pharma Private Limited, buy the company report.
Auditor
Drexel Pharma Private Limited is audited by Kakaria and Associates LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kakaria and Associates LLP | FY 2022 | 104558W/W100601 |
Shareholding
The shareholding of Drexel Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Drexel Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Drexel Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Drexel Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Drexel Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Drexel Pharma Private Limited has 9 board changes on record since 2011: 2 appointments and 7 cessations. The latest: Ajay Thakorbhai Desai ceased to be Additional Director on 20 Sep 2011.
Frequently asked questions
Drexel Pharma is an active private limited company based in Silvassa, Dadra And Nagar Haveli, India. The company works in crop protection, within the agriculture industry. It was incorporated on 18 November 1987 (39+ years old) and is registered under CIN U51900DN1987PTC005546.
Drexel Pharma has 2 current directors:
- Vijay Thakorbhai Desai - Director
- Ajay Thakorbhai Desai - Director
The latest financial statements of Drexel Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Drexel Pharma is U51900DN1987PTC005546. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Drexel Pharma was incorporated on 18 November 1987, making it 39+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Drexel Pharma by revenue are M D Marketing Private Limited, Srish Chem Private Limited, Skynet Overseas Private Limited, India Health Services Private Limited, Superking Silicate Private Limited and 5 more, all in the Chemicals industry (Industrial Chemicals).
Ajay Thakorbhai Desai ceased to be Additional Director on 20 Sep 2011. Vijay Thakorbhai Desai ceased to be Additional Director on 20 Sep 2011. Dipti Rishikesh Shah ceased to be Director on 20 Jan 2011. Drexel Pharma has 9 board changes on record in total.
The registered office of Drexel Pharma is at G – 1 Krunal Apartment Opp. Vinoba Bhave Civil Hospital Silvassa Dadra And Nagar Have, Li, Dadra and Nagar Haveli, India – 396230.
Drexel Pharma operates in the agriculture industry, in the crop protection segment.
The compliance status of Drexel Pharma is compliant as of 25 July 2026. The company is actively filing with the Registrar of Companies.
Drexel Pharma can be reached at its registered office: G – 1 Krunal Apartment Opp. Vinoba Bhave Civil Hospital Silvassa Dadra And Nagar Have, Li, Dadra and Nagar Haveli, India – 396230.

